Amplitude Surgical (1AU.SG)
| Previous close | 2.8000 |
| Open | 2.8000 |
| Bid | 2.8200 x 0 |
| Ask | 2.9600 x 0 |
| Day's range | 2.8000 - 2.8200 |
| 52-week range | 2.8000 - 3.5600 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 20 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireAmplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of €79.6m, up +6.1% at Constant Exchange Rates
VALENCE, France, April 18, 2024--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its consolidated sales for the third quarter of the 2023-24 financial year.
Business WireAmplitude Surgical Announces H1 2023-2024 Results: €49.1m Sales and €11.8m EBITDA
VALENCE, France, March 20, 2024--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible) (Paris:AMPLI), leading French player on the surgical technology market for lower-limb orthopedics, announces its results for the first half of the 2023-24 financial year.
Business WireAmplitude Surgical Posts H1 2023-24 Consolidated Sales of €49.1 M, +9.4% at Constant Exchange Rates
VALENCE, France, February 22, 2024--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), French leader on the global surgical technology market for lower-limb orthopedics, today announces its half-year consolidated sales of the 2023-24 financial year.
